| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.25 | 6e-06 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.19 | 0.006 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.088 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.07 | 0.2 |